The reality of low productivity of current pharmaceutical research in terms of new molecules and rising cost of development begs a fresh approach to creativity. This is coupled with major trust issues as a perceived lack of transparency which has eroded confidence in both pharmaceutical companies and the public institutions that regulate them.
|Title of host publication||Value Creation in the Pharmaceutical Industry|
|Editors||Alexander Schuhmacher, Markus Hinder, Oliver Gassmann|
|Place of Publication||Weinheim|
|Number of pages||16|
|Publication status||Published - 15 Jan 2016|